Skip to main content
. 2023 Aug 17;13:1210314. doi: 10.3389/fonc.2023.1210314

Table 2.

Relationship between HER-2 expression intensity and prognosis.

Recurrence/metastasis HER-2 ultra-low, n (%) HER-2 low, n (%) P
Total 0.082
Yes 29 (11.6) 60 (8.0)
No 22 (88.4) 688 (92.0)
TNBC subgroup 0.195
Yes 11 (16.4) 7 (9.2)
No 56 (83.6) 69 (90.8)
HR-positive subgroup 0.385
Yes 18 (9.9) 53 (7.9)
No 164 (90.1) 619 (92.1)